The effects of N-acetylcysteine on recovery biomarkers: Asystematic review and meta-analysis of controlled trials.

Abstract

N-acetylcysteine (NAC) is one of the antioxidant supplements which is thought to improve recovery. Existing studies regarding NAC and recovery presented conflicting results. This systematic review and meta-analysis evaluated the existing trials and determined the efficacy of acute and chronic NAC administration on recovery biomarkers. PubMed, Web of Science, and Scopus were searched up to July 2021. The random effects or fixed effects model was applied in the meta-analysis. Sensitivity and subgroup analyses were performed. In case of the presence of publication bias, standard methods were applied. The meta-analysis comprised 37 papers (1,388 participants). All included studies were in English language. Acute NAC administration indicated no significant effects on lactate, pH, VO2 , and CPK-MB ([SMD=-0.06mmol/L; 95% CI: -0.40, 0.28; p=.714], [SMD=0.17; 95% CI: -0.28, 0.62; p=.454], [SMD=-0.11L/min; 95% CI: -0.63, 0.41; p=.686], and [SMD=-0.19units/L; 95% CI: -0.62, 0.24; p=.395]). Additionally, no evidence of significant influence of chronic NAC administration on lactate, pH, VO2 , and CK was revealed ([SMD=0.01mmol/L; 95% CI: -0.25, 0.27; p=.950], [SMD=-0.51; 95% CI: -1.73, 0.70; p=.424], [SMD=-0.18L/min; 95% CI: -0.56, 0.20; p=.361], and [SMD=-0.04units/L; 95% CI: -0.36, 0.29; p=.821]). No considerable effect of NAC on recovery was found. PRACTICAL APPLICATIONS: Previous studies on the influence of NAC administration on recovery biomarkers have presented conflicting results. This systematic review and meta-analysis offers a broad range of detailed information on the influence of chronic and acute NAC supplementation outcomes regarding recovery biomarkers. Overall, the results support that NAC supplementation may not be effective in improving recovery biomarkers. However, subgroup analyses based on NAC dosage indicated the meaningful effect of NAC on CK-MB at the dosage of ≥100mg/kg.